[Effect of cardiovascular drugs on electrolyte metabolism (review of the literature)].
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002301:Cardiac Glycosides / Q000494:pharmacology* / Q000506:poisoning; D004232:Diuretics / Q000494:pharmacology; D004285:Dogs; D006145:Guanethidine / Q000494:pharmacology; D006168:Guinea Pigs; D008274:Magnesium / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011342:Procainamide / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012964:Sodium / Q000378:metabolism; D013328:Strophanthins / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D013328:Strophanthins; D014665:Vasodilator Agents; D012110:Reserpine; D012964:Sodium; D011433:Propranolol; D000251:Adenosine Triphosphatases; D008274:Magnesium; D011802:Quinidine; D011342:Procainamide; D011188:Potassium; D002118:Calcium; D006145:Guanethidine
Deĭstvie serdechno-sosudistykh sredstv na élektrolitnyĭ obmen (obzor literatury)